Prognostic value of NDRG1 and SPARC protein expression in breast cancer patients Maria Aparecida NagaiRenê GerhardFernando A. Soares Preclinical study 06 April 2010 Pages: 1 - 14
RETRACTED ARTICLE: Platelet-derived growth factor-D contributes to aggressiveness of breast cancer cells by up-regulating Notch and NF-κB signaling pathways Aamir AhmadZhiwei WangFazlul H. Sarkar Preclinical study 09 April 2010 Pages: 15 - 25
The ErbB3 binding protein EBP1 regulates ErbB2 protein levels and tamoxifen sensitivity in breast cancer cells Yan LuHua ZhouAnne W. Hamburger Preclinical study 09 April 2010 Pages: 27 - 36
A systematic review of the relationship between polymorphic sites in the estrogen receptor-beta (ESR2) gene and breast cancer risk Ke-Da YuNan-Yan RaoZhi-Ming Shao Preclinical study 14 April 2010 Pages: 37 - 45
CTEN (C-terminal tensin-like), a novel oncogene overexpressed in invasive breast carcinoma of poor prognosis Abdulkader AlbasriMohammed AleskandaranyAndrew R. Green Preclinical study 14 April 2010 Pages: 47 - 54
Uptake of 2-NBDG as a method to monitor therapy response in breast cancer cell lines Stacy R. MillonJulie H. OstranderNirmala Ramanujam Preclinical study 14 April 2010 Pages: 55 - 62
Role of ferritin alterations in human breast cancer cells Svitlana I. ShpylevaVolodymyr P. TryndyakIgor P. Pogribny Preclinical study 13 April 2010 Pages: 63 - 71
Interactions between breast cancer cells and bone marrow derived cells in vitro define a role for osteopontin in affecting breast cancer cell migration Konstantin KoroStephen ParkinAnthony Magliocco Preclinical study 17 April 2010 Pages: 73 - 83
Does radiotherapy planning without breath control compensate intra-fraction heart and its compartments’ movement? Evrim Kadriye TezcanliEvren Ozan GokselIşik Aslay Clinical trial 24 December 2010 Pages: 85 - 92
Phosphorylated S6K1 is a possible marker for endocrine therapy resistance in hormone receptor-positive breast cancer Eun-Kyu KimHyun-Ah KimWoo Chul Noh Clinical trial 24 December 2010 Pages: 93 - 99
Results of a phase II study of pemetrexed as first-line chemotherapy in patients with advanced or metastatic breast cancer Nicholas J. RobertPaul R. ConklingJoyce A. O’Shaughnessy Clinical trial 25 December 2010 Pages: 101 - 108
Comparison of different approaches for assessment of HER2 expression on protein and mRNA level: prediction of chemotherapy response in the neoadjuvant GeparTrio trial (NCT00544765) A. NoskeS. LoiblG. von Minckwitz Clinical trial 29 December 2010 Pages: 109 - 117
Comprehensive genetic characterization of hereditary breast/ovarian cancer families from Slovakia Michal KonecnyMiriam MillyZdena Bartosova Clinical trial 04 January 2011 Pages: 119 - 130
Bilateral breast cancer: analysis of incidence, outcome, survival and disease characteristics Elrasheid A. H. KheirelseidHanzali JumustafaMichael J. Kerin Epidemiology 28 July 2010 Pages: 131 - 140
Association between polymorphisms of the ataxia telangiectasia mutated gene and breast cancer risk: evidence from the current studies Pei-Hua LuMu-Xin WeiMin-Bin Chen Epidemiology 28 July 2010 Pages: 141 - 148
Effect of aspirin and other NSAIDs on postmenopausal breast cancer incidence by hormone receptor status: results from a prospective cohort study Aditya BardiaJanet E. OlsonJames R. Cerhan Epidemiology 29 July 2010 Pages: 149 - 155
Genetic variants in COX-2, non-steroidal anti-inflammatory drugs, and breast cancer risk: the Western New York Exposures and Breast Cancer (WEB) Study Theodore M. BraskyMatthew R. BonnerJo L. Freudenheim Epidemiology 30 July 2010 Pages: 157 - 165
Effects of breast cancer surgery and surgical side effects on body image over time Karen Kadela CollinsYing LiuDonna B. Jeffe Epidemiology 05 August 2010 Pages: 167 - 176
Association between polymorphisms of trinucleotide repeat containing 9 gene and breast cancer risk: evidence from 62,005 subjects Min-Bin ChenXiao-Yang WuPei-Hua Lu Epidemiology 12 August 2010 Pages: 177 - 183
Defining breast cancer prognosis based on molecular phenotypes: results from a large cohort study Shaheenah DawoodRong HuRulla M. Tamimi Epidemiology 14 August 2010 Pages: 185 - 192
Body weight and risk of breast cancer in BRCA1/2 mutation carriers Peggy MandersAnouk PijpeMatti A. Rookus Epidemiology 21 August 2010 Pages: 193 - 202
The RING heterodimer BRCA1–BARD1 is a ubiquitin ligase inactivated by the platinum-based anticancer drugs Apichart AtipairinBhutorn CanyukAdisorn Ratanaphan Brief Report 29 September 2010 Pages: 203 - 209
Invasive ductal breast cancer associated polymyositis causing respiratory failure Xi LiWanshou QiuRenbin Liu Brief Report 08 October 2010 Pages: 211 - 214
Evaluation of metformin in early breast cancer: a modification of the traditional paradigm for clinical testing of anti-cancer agents Pamela J. GoodwinVuk StambolicLois E. Shepherd Brief Report 26 October 2010 Pages: 215 - 220
Cognitive function in postmenopausal breast cancer patients one year after completing adjuvant endocrine therapy with letrozole and/or tamoxifen in the BIG 1-98 trial Kelly-Anne PhillipsJulie AldridgeJürg Bernhard Brief Report 03 November 2010 Pages: 221 - 226
Germline mutations in PALB2 in African-American breast cancer cases Yuan Chun DingLinda SteeleSusan L. Neuhausen Brief Report 27 November 2010 Pages: 227 - 230
Reversed urban–rural differences in breast cancer mortality (China, 2002–2008) Min HeQulian GuoGuoqing Hu Brief Report 01 December 2010 Pages: 231 - 234
No evidence for an association between the earwax-associated polymorphism in ABCC11 and breast cancer risk in Caucasian women Jonathan BeesleySharon E. JohnattyGeorgia Chenevix-Trench Brief Report 17 December 2010 Pages: 235 - 239
Diagnostic utility of mammaglobin and GCDFP-15 in the identification of primary neuroendocrine carcinomas of the breast Eugeni Lopez-BonetMaria Carmen Pérez-MartínezJavier A. Menendez Letter to the Editor 27 October 2010 Pages: 241 - 245
Comments on: Iwasaki et al. Fragment c gamma receptor gene polymorphisms and breast cancer risk in case–control studies in Japanese, Japanese Brazilians, and non-Japanese Brazilians Janardan P. Pandey Letter to the editor 27 October 2010 Pages: 247 - 248
A small number of subjects do not always indicate that they are minor variants data for inclusion in a pooled analysis Pei-Hua LuMin-Bin ChenChen Li Letter to the Editor 03 November 2010 Pages: 249 - 252
Polymorphisms of tumor necrosis factor-alpha and breast cancer risk: appraisal of a recent meta-analysis Ping ZhouJian-Ping LiChun Zhang Letter to the Editor 03 November 2010 Pages: 253 - 256
No association of polymorphisms in the cell polarity gene SCRIB with breast cancer risk in German population Chun ZhangPing ZhouJian-Ping Li Letter to the Editor 18 November 2010 Pages: 257 - 259
Effects of breast cancer surgery and surgical side effects on body image over time Alexandre Mendonça MunhozRolf GemperliJosé Roberto Filassi Letter to the Editor 26 November 2010 Pages: 261 - 262
Effects of breast cancer surgery and surgical side effects on body image over time Karen Kadela CollinsMaria PérezDonna B. Jeffe REBUTTAL LETTER 22 December 2010 Pages: 263 - 264
New conflicting results obtained in the subgroup analysis of RAD51 135G>C polymorphism and breast cancer risk Pei-Hua LuMin-Bin ChenGuo-Qing Tao Letter to the Editor 26 November 2010 Pages: 265 - 266
Erratum to: A pilot study of dose-dense adjuvant paclitaxel without growth factor support for women with early breast carcinoma Steven SugarmanCarolyn WasserheitClifford Hudis Erratum 22 July 2009 Pages: 267 - 267
Erratum to: Expression profiling of familial breast cancers demonstrates higher expression of FGFR2 in BRCA2-associated tumors Anita L. BaneDushanthi PinnaduwageIrene L. Andrulis Erratum 06 October 2009 Pages: 269 - 269
Erratum to: The cognitive effects of chemotherapy in post-menopausal breast cancer patients: a controlled longitudinal study Felice A. TagerPaula S. McKinleyDawn L. Hershman Erratum 06 January 2010 Pages: 271 - 272
